|
DPH5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.090620E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.593400E-01 |
| Normal-vs-Stage2 |
3.400200E-01 |
| Normal-vs-Stage3 |
7.643000E-01 |
| Normal-vs-Stage4 |
2.992400E-02 |
| Stage1-vs-Stage2 |
8.317600E-01 |
| Stage1-vs-Stage3 |
6.043200E-01 |
| Stage1-vs-Stage4 |
1.297550E-02 |
| Stage2-vs-Stage3 |
5.682000E-01 |
| Stage2-vs-Stage4 |
6.609900E-02 |
| Stage3-vs-Stage4 |
1.612170E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.243900E-02 |
| Normal-vs-AfricanAmerican |
4.596600E-01 |
| Normal-vs-Asian |
5.158600E-01 |
| Caucasian-vs-AfricanAmerican |
2.936400E-01 |
| Caucasian-vs-Asian |
8.282400E-01 |
| AfricanAmerican-vs-Asian |
5.389400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.764000E-01 |
| Normal-vs-Female |
3.279600E-02 |
| Male-vs-Female |
1.113360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.014440E-01 |
| Normal-vs-Extreme_Weight |
1.756040E-01 |
| Normal-vs-Obese |
2.126600E-01 |
| Normal-vs-Extreme_Obese |
6.177800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.093000E-01 |
| Normal_Weight-vs-Obese |
6.681000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.844600E-01 |
| Extreme_Weight-vs-Obese |
9.536400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.748600E-01 |
| Obese-vs-Extreme_Obese |
7.859600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.679400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.996200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.342000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.540300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.672200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.233900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.541800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.185800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.823200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.228000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.941410E-01 |
| Normal-VS-Type2 PRCC |
3.443400E-01 |
| Normal-VS-KIRP CIMP |
3.774800E-01 |
| Normal-VS-Unclassified PRCC |
2.252000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.444800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.758200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.361000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.429200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.431400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.377800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.235400E-01 |
| Normal-vs-N1 |
5.356100E-02 |
| Normal-vs-N2 |
3.933600E-01 |
| N0-vs-N1 |
1.290220E-01 |
| N0-vs-N2 |
4.126800E-01 |
| N1-vs-N2 |
5.041400E-01 |
|
|
